AGP Executive Report
Last update: 6 hours agoBiomanufacturing Expansion: Argentine biotech Biosidus finished a $12.9m expansion to triple cell-culture capacity, boosting production of its agalsidase beta biosimilar and aiming to meet rising international demand. Public Health Clash: Pennsylvania’s first measles-related deaths in decades sparked a political fight over vaccination claims, with officials and federal leadership trading accusations as experts warn the dispute is distracting from the outbreak. Vaccines in Motion: Venezuela received 392,000 polio vaccine doses to update childhood immunization schedules, while Nigeria deployed 500,000 diphtheria doses to Kano and Katsina and activated an emergency task force to close immunization gaps. Drug Pricing Pressure: Pakistan’s economic affairs minister ordered DRAP to revise drug pricing rules and hardship provisions, targeting unjustified medicine price increases. Overdose Response: Mississippi’s mental health department will hold an Overdose Awareness Day press conference, highlighting progress in overdose deaths and expanding access to naloxone. Safety Watch: The FDA issued a recall for certain IV saline bags over possible fiberglass contamination. Care Access Gap: A new report finds over 2 million women in the U.S. live in maternal care deserts, underscoring persistent rural OB-GYN shortages. Global Ebola Focus: Coverage highlights the widening DRC Ebola outbreak and the urgent need for speed, scale, and solidarity.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.